1-2 of 2
Sandra Croockewit, MD, PhD
Close
Sort by
Journal Articles

Final Analysis of HOVON-50 Randomized Phase III Study on the Effect of Thalidomide Combined with Adriamycine, Dexamethasone (AD) and High Dose Melphalan (HDM) in Patients with Multiple Myeloma (MM)

Henk Lokhorst, Bronno van der Holt, Sonja Zweegman, MD, PhD, Peter A. Von Dem Borne, MD, PhD, Gerard M.J. Bos, MD, PhD, Sandra Croockewit, MD, PhD, Jan J. Cornelissen, MD, PhD, Marinus van Oers, Martyn Ronald Schaafsma, Harm Sinnige, MD, PhD, Michel Delforge, MD, PhD, Okke de Weerdt, Pierre W Wijermans, Shulamiet Wittebol, MD, PhD, Edo Vellenga, MD, PhD, Asiong Jie, Henriette Berenschot, MD, PhD, Marinus Marwijk-kooy, MD, PhD, Pieter Sonneveld, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 157.
https://doi.org/10.1182/blood.V112.11.157.157
Published: 2008
Journal Articles

High-Dose Therapy in AL Amyloidosis: A Prospective Phase II Study by the Dutch-Belgian Cooperative Group (HOVON)

Bouke P.C. Hazenberg, MD, PhD, Sandra Croockewit, MD, PhD, Ron van der Holt, MD, PhD, Sonja Zweegman, MD, PhD, Gerard Bos, MD, PhD, Peter Vandenberghe, MD, PhD, Pieter Sonneveld, MD, PhD, Jan J. Cornelissen, MD, PhD, Edo Vellenga, MD, PhD, Pierre W. Wijermans, MD, PhD, Roelof Willemze, MD, PhD, Marinus H.J. Van Oers, MD, PhD, Okke de Weerdt, Fokje M. Spoelstra, PhD, Henk Lokhorst, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 163.
https://doi.org/10.1182/blood.V112.11.163.163
Published: 2008